International Medical Innovations prepares for the launch of its first product and forecasts sales in 1999
This article was originally published in Clinica
Executive Summary
The Canadian biotechnology company, International Medical Innovations (IMI), aims to start generating product revenues from early 1999 once its first product, the Cholesterol 1,2,3, reaches the market.